What the Depo-Provera Label Change Means for Brain Tumor Lawsuits

Depo-Provera has been prescribed to millions of women as a long-acting birth control option. For years, many patients relied on the shot without being warned that prolonged use could increase the risk of developing a type of tumor that can cause serious neurological complications.

Recent changes to Depo-Provera’s U.S. warning label, along with a growing number of women filing Depo-Provera lawsuits against the drug’s manufacturer, have raised urgent questions for women who used the shot and were later diagnosed with a brain tumor. At Childers, Schlueter & Smith (CSS), we help women understand whether their injuries may be connected to Depo-Provera and explore the legal options available to them.

What the Depo-Provera Label Change Means

In December 2025, the FDA approved a change to Depo-Provera’s U.S. warning label to include information about the risk of developing brain meningiomas. By the time this update was added, similar warnings had already appeared on Depo-Provera labels in other countries, raising concerns among patients and advocates about how long U.S. consumers went without this safety information. 

Lawsuits involving Depo-Provera allege that the delayed warning left patients and their doctors unable to make fully informed decisions about birth control options.

For many women, this label change came too late. Earlier warnings, plaintiffs argue, could have reduced prolonged exposure to the drug and helped prevent serious and life-altering injuries. As these claims have grown, federal courts consolidated many Depo-Provera brain tumor lawsuits into a multidistrict litigation (MDL) to streamline pretrial proceedings while allowing each woman to pursue her individual case.

How is Depo-Provera Linked to Brain Tumors

Medical research has increasingly linked long-term exposure to medroxyprogesterone acetate, the active ingredient in Depo-Provera, to an elevated risk of brain meningiomas. A study published in the British Medical Journal found that women who used the birth control shot for at least one year faced a significantly higher risk of developing these tumors.

Although many meningiomas are non-cancerous, their location in the brain can lead to severe symptoms, including chronic headaches, seizures, vision changes, and the need for complex surgery. Many women report that they were never warned about these risks and say they would have chosen a different form of birth control if they had known.

Depo-Provera Lawsuit FAQs

• What is a Depo-Provera brain meningioma?
  A brain meningioma is a tumor that forms in the membranes surrounding the brain and spinal cord. While often non-cancerous, these tumors can still cause serious neurological symptoms and may require surgery.
• How long did women typically use Depo-Provera before developing tumors?
  Many lawsuits involve women who used Depo-Provera for one year or longer, though individual cases vary.
• Do I qualify for a Depo-Provera lawsuit?
  You may qualify if you used Depo-Provera and were later diagnosed with a brain meningioma or related complications. An attorney can review your medical and prescription history to help determine eligibility.
• Is the Depo-Provera litigation ongoing?
  Yes. Depo-Provera brain tumor lawsuits are still being filed, and federal litigation is expected to continue as more women learn about the potential risks.

Talk With a Depo-Provera Injury Lawyer

If you used Depo-Provera and were later diagnosed with a brain tumor, you may be wondering whether your condition could be connected to the drug. Our attorneys work with women nationwide to review medical histories, explain ongoing litigation, and determine whether a claim may be appropriate.

We understand that these diagnoses are overwhelming. Our goal is to provide clear guidance, answer your questions honestly, and pursue accountability on your behalf while you focus on your health and recovery. Call us at 1-800-641-0098, use our live online chat, or contact us online for a free consultation.